ArticleBreast cancer research : BCR2026

CorePAM: a 24-gene PAM50-derived expression score with cross-platform external validation for breast cancer prognosis.

Rafael de Negreiros Botan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.